Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Proteome Sciences plc (PRM) Ordinary 1p

Sell:3.00p Buy:3.48p 0 Change: 0.23p (7.08%)
Market closed Prices as at close on 19 November 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3.00p
Buy:3.48p
Change: 0.23p (7.08%)
Market closed Prices as at close on 19 November 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3.00p
Buy:3.48p
Change: 0.23p (7.08%)
Market closed Prices as at close on 19 November 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.

Contact details

Address:
Hamilton House, Mabledon Place
LONDON
WC1H 9BB
United Kingdom
Telephone:
+44 (020) 70432116
Website:
https://www.proteomics.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 31 October 2019 31/10/19
Interim results 25 July 2019 25/07/19
Final results 30 April 2019 30/04/19
AGM 30 April 2019 30/04/19
Final results 02 April 2019 02/04/19
Trading Announcement 23 January 2019 23/01/19

General stock information

EPIC:
PRM
ISIN:
GB0003104196
Market cap:
£8.91 million
Shares in issue:
295.18 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Christopher Pearce
    Executive Chairman of the Board
  • Jeremy Haigh
    Chief Executive Officer, Director
  • Geoffrey Ellis
    Finance Director, Company Secretary, Director
  • Ian Pike
    Chief Operating Officer, Executive Director
  • Malcolm Ward
    Chief Technical Officer - London Research Facility
  • Glenn Barney
    Vice President - Business Development, USA
  • Richard Dennis
    Chief Commercial Officer
  • Josef Schwarz
    Head - Projects & Production, Proteome Sciences R&D

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.